Literature DB >> 648582

A comparison of the oximes HS-6 and HI-6 in the therapy of soman intoxication in rodents.

L A Kepner, O L Wolthuis.   

Abstract

The bisquaternary mono-oximes HS-6 and HI-6 may both be considered as potential therapeutic agents for soman intoxication. It has been found that HI-6 was superior to an equal dose of /S-6 in the treatment of soman intoxication in mice and rats. Not only did HI-6 protect against higher levels of soman, but also fewer "delayed deaths" were seen following HI-6. In anesthetized atropinized rats, the administration of HI-6 resulted in a longer duration of spontaneous breathing and a higher degree of recovery of neuromuscular function than did the use of HS-6. HS-6 interacted with soman to alter the rate of excretion of the oxime. This problem was not encountered when HI-6 was used.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 648582     DOI: 10.1016/0014-2999(78)90164-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

1.  Distribution of the bispyridinium oxime [14C] HI-6 in male and female rats.

Authors:  P M Lundy; B T Hand; B R Broxup; G Yipchuck; M G Hamilton
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

2.  The acetylcholinesterase reactivator HI-6 (1-[[[4-(aminocarbonyl)pyridinio]methoxyl]methyl]- 2-[(hydroxyimino)methyl]-pyridinium dichloride): a comparative study of HI-6 samples from various sources.

Authors:  J G Clement; P A Lockwood; H G Thompson
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

3.  Pharmacokinetics of pralidoxime chloride. A comparative study in healthy volunteers and in organophosphorus poisoning.

Authors:  D Jovanović
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

4.  Reactivating and protective effects of pyridinium compounds in human erythrocyte acetylcholinesterase inhibition by organophosphates in vitro.

Authors:  M Skrinjarić-Spoljar; M Kralj
Journal:  Arch Toxicol       Date:  1980-05       Impact factor: 5.153

5.  Survivors of soman poisoning: recovery of the soman LD50 to control value in the presence of extensive acetylcholinesterase inhibition.

Authors:  J G Clement
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

6.  Delayed neuropathy by the organophosphorus nerve agents soman and tabun.

Authors:  J L Willems; M Nicaise; H C De Bisschop
Journal:  Arch Toxicol       Date:  1984-03       Impact factor: 5.153

7.  Plasma concentrations of pralidoxime methylsulphate in organophosphorus poisoned patients.

Authors:  J L Willems; J P Langenberg; A G Verstraete; M De Loose; B Vanhaesebroeck; G Goethals; F M Belpaire; W A Buylaert; D Vogelaers; F Colardyn
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

8.  Pharmacokinetics and pharmacodynamics of the oxime HI6 in dogs.

Authors:  R Klimmek; P Eyer
Journal:  Arch Toxicol       Date:  1986-12       Impact factor: 5.153

9.  The influence of 2-/o-cresyl/-4 H-1 : 3 : 2-benzodioxa-phosphorin-2-oxide (CBDP) on organophosphate poisoning and its therapy.

Authors:  B Bosković
Journal:  Arch Toxicol       Date:  1979-07-11       Impact factor: 5.153

10.  Rapid absorption from the urinary bladder of a series of n-alkyl carbamates: a route for the recirculation of drugs.

Authors:  J W Bridges; N S Sargent; D G Upshall
Journal:  Br J Pharmacol       Date:  1979-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.